Eagle Pharmaceuticals EPS - Earnings per Share 2013-2023 | EGRX
Eagle Pharmaceuticals eps - earnings per share from 2013 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Eagle Pharmaceuticals Annual EPS | |
|---|---|
| 2022 | $2.73 |
| 2021 | $-0.66 |
| 2020 | $0.87 |
| 2019 | $1.01 |
| 2018 | $2.09 |
| 2017 | $3.27 |
| 2016 | $4.96 |
| 2015 | $0.16 |
| 2014 | $0.00 |
| 2014 | $-1.97 |
| 2013 | $-3.25 |
| 2012 | $0.00 |
| 2012 | $-14.11 |
| 2011 | $0.00 |
| Eagle Pharmaceuticals Quarterly EPS | |
|---|---|
| 2023-06-30 | $0.39 |
| 2023-03-31 | $0.44 |
| 2022-12-31 | $0.60 |
| 2022-09-30 | $-0.54 |
| 2022-06-30 | $-0.74 |
| 2022-03-31 | $3.41 |
| 2021-12-31 | $-0.47 |
| 2021-09-30 | $-0.43 |
| 2021-06-30 | $0.27 |
| 2021-03-31 | $-0.03 |
| 2020-12-31 | $0.59 |
| 2020-09-30 | $0.51 |
| 2020-06-30 | $-0.02 |
| 2020-03-31 | $-0.21 |
| 2019-12-31 | $0.08 |
| 2019-09-30 | $-0.17 |
| 2019-06-30 | $0.48 |
| 2019-03-31 | $0.62 |
| 2018-12-31 | $0.84 |
| 2018-09-30 | $0.91 |
| 2018-06-30 | $0.17 |
| 2018-03-31 | $0.17 |
| 2017-12-31 | $0.59 |
| 2017-09-30 | $0.98 |
| 2017-06-30 | $0.28 |
| 2017-03-31 | $1.42 |
| 2016-12-31 | $3.49 |
| 2016-09-30 | $0.73 |
| 2016-06-30 | $0.80 |
| 2016-03-31 | $-0.06 |
| 2015-12-31 | $0.03 |
| 2015-09-30 | $-0.65 |
| 2015-06-30 | $-0.53 |
| 2015-03-31 | $1.31 |
| 2014-12-31 | $-0.39 |
| 2014-09-30 | $-0.65 |
| 2014-06-30 | $-0.21 |
| 2014-03-31 | $-0.36 |
| 2013-12-31 | $-1.44 |
| 2013-09-30 | $-0.21 |
| 2013-06-30 | $-0.11 |
| 2013-03-31 | $-1.84 |
| 2012-09-30 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.061B | $0.317B |
| Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.939B | 23.69 |
| Stryker (SYK) | United States | $123.542B | 29.59 |
| Medtronic (MDT) | Ireland | $111.935B | 15.85 |
| Boston Scientific (BSX) | United States | $107.817B | 34.34 |
| EssilorLuxottica (ESLOY) | France | $101.153B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.922B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.990B | 27.73 |
| ResMed (RMD) | United States | $31.710B | 29.77 |
| Terumo (TRUMY) | Japan | $25.565B | 36.10 |
| Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.681B | 15.77 |
| Baxter (BAX) | United States | $17.958B | 12.77 |
| Insulet (PODD) | United States | $12.066B | 53.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.266B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.385B | 27.43 |
| BellRing Brands (BRBR) | United States | $7.844B | 36.74 |
| Lantheus Holdings (LNTH) | United States | $5.455B | 13.59 |
| Haemonetics (HAE) | United States | $4.945B | 24.47 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.129B | 12.52 |
| Prestige Consumer Healthcare (PBH) | United States | $3.548B | 16.98 |
| Envista Holdings (NVST) | United States | $3.295B | 13.60 |
| QuidelOrtho (QDEL) | United States | $2.959B | 16.42 |
| Neogen (NEOG) | United States | $2.835B | 27.27 |
| TG Therapeutics (TGTX) | United States | $2.776B | 78.09 |
| Green Thumb Industries (GTBIF) | United States | $2.714B | 53.75 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.690B | 0.00 |
| ICU Medical (ICUI) | United States | $2.565B | 22.63 |
| Agios Pharmaceuticals (AGIO) | United States | $1.938B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.927B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.34 |
| InMode (INMD) | Israel | $1.560B | 8.29 |
| Warby Parker (WRBY) | United States | $1.543B | 0.00 |
| Owens & Minor (OMI) | United States | $1.513B | 13.19 |
| AdaptHealth (AHCO) | United States | $1.306B | 9.73 |
| National Vision Holdings (EYE) | United States | $1.200B | 38.20 |
| AtriCure (ATRC) | United States | $1.042B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.032B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.983B | 0.00 |
| Evolus (EOLS) | United States | $0.799B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.738B | 15.70 |
| Cresco Labs (CRLBF) | United States | $0.698B | 0.00 |
| Quanterix (QTRX) | United States | $0.644B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.631B | 14.83 |
| PetIQ (PETQ) | United States | $0.576B | 18.82 |
| Valneva SE (VALN) | France | $0.558B | 0.00 |
| Jin Medical (ZJYL) | China | $0.522B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.471B | 29.46 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.443B | 8.50 |
| OraSure Technologies (OSUR) | United States | $0.403B | 12.98 |
| Aurora Cannabis (ACB) | Canada | $0.382B | 0.00 |
| Cerus (CERS) | United States | $0.377B | 0.00 |
| Zynex (ZYXI) | United States | $0.345B | 47.22 |
| MacroGenics (MGNX) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 25.77 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.164B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.152B | 73.06 |
| InterCure (INCR) | Israel | $0.148B | 24.96 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.36 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 8.94 |
| Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.090B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.067B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.08 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |